 |
October 2016 Prosenex is finalist in worldwide T1D/M2D2 Diabetes Inovation Challenge "From an impressive field of over 60 inspiring applicants"
June 2016 Prosenex wins bronze medal at the global
Medical Design Excellence Awards (MDEA)
September 2015, Prosenex exhibits at the WOW 2015- Wild on Wounds - Wound Care Conference.
March 2015, Prosenex exhibits at the DFCon - Diabetic Foot Global Conference.
January 2015, Prosenex exhibits at the NY15 New York Podiatrical Clinical Conference
***November 2014, The Dynamic Neuroscreening Device Wins the Award for Product of the Year from the New Hampshire High Tech Council
November 2014, Prosenex exhibits at the
CFPM 15TH ANNUAL CONFERENCE - NOV 6 - 8, 2014
SHERATON ON THE FALLS, NIAGARA FALLS, ON
**October 2014, The Dynamic Neuroscreening Device Receives the Judges Award Winner distinction for Product of the Year from the New Hampshire High Tech Council
July 2014, Prosenex receives notice from the FDA that the DND has received 510K clearance (K141208) and is now available for sale in the USA.
January 2014, Prosenex granted Health Canada Medical Device Establishment License # 5950.
July 2013, Prosenex Patent Application for the DND was granted by the US Patent Office.
U.S. Patent No. 8,579,830
|
|
|
